Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Mark Frendl, Ph.D., M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Frendl DM, FitzGerald G, Epstein MM, Allison JJ, Sokoloff MH, Ware JE. Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool. PLoS One. 2020; 15(12):e0240039. PMID: 33284845.
    Citations:    Fields:    Translation:Humans
  2. Frendl DM, Chen YW, Chang DC, Kim MM. A Claims Based Assessment of Reoperation and Acute Urinary Retention after Ambulatory Transurethral Surgery for Benign Prostatic Hyperplasia. J Urol. 2021 02; 205(2):532-538. PMID: 33026901.
    Citations:    Fields:    Translation:Humans
  3. Frendl DM, Epstein MM, Fouayzi H, Krajenta R, Rybicki BA, Sokoloff MH. Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data. Cancer Causes Control. 2020 Sep; 31(9):861-867. PMID: 32556947.
    Citations:    Fields:    Translation:Humans
  4. Zhang H, Frendl DM, Wang Z, Olumi AF. Reply by Authors. J Urol. 2020 08; 204(2):331. PMID: 32436767.
    Citations:    Fields:    
  5. Zhang H, Frendl DM, Wang Z, Olumi AF. High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia. J Urol. 2020 Aug; 204(2):325-331. PMID: 32167867.
    Citations:    Fields:    Translation:Humans
  6. Frendl DM, Olumi AF. Understanding temporal trends in medical costs associated with progression to metastatic prostate cancer. Cancer. 2017 09 15; 123(18):3447-3449. PMID: 28542736.
    Citations:    Fields:    Translation:Humans
  7. Cramon P, Bonnema SJ, Bjorner JB, Ekholm O, Feldt-Rasmussen U, Frendl DM, Groenvold M, Hegedüs L, Rasmussen ÅK, Watt T. Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population. Thyroid. 2015 Mar; 25(3):284-91. PMID: 25602312.
    Citations: 14     Fields:    Translation:Humans
  8. Frendl DM, Sokoloff MH. Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancer. Med Care. 2014 Jul; 52(7):576-8. PMID: 24926703.
    Citations:    Fields:    Translation:Humans
  9. Frendl DM, Ware JE. Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey. Med Care. 2014 May; 52(5):439-45. PMID: 24714581.
    Citations: 21     Fields:    Translation:Humans
  10. Watt T, Cramon P, Frendl DM, Ware JE. Assessing health-related quality of life in patients with benign non-toxic goitre. Best Pract Res Clin Endocrinol Metab. 2014 Aug; 28(4):559-75. PMID: 25047206.
    Citations: 3     Fields:    Translation:Humans
  11. Frendl DM, Palmeri ST, Clapp JR, Hampton D, Sejersten M, Young D, Drew B, Farrell R, Innes J, Russell J, Rowlandson GI, Purim-Shem-Tov Y, Underhill BK, Zhou S, Wagner GS. Overcoming barriers to developing seamless ST-segment elevation myocardial infarction care systems in the United States: recommendations from a comprehensive Prehospital 12-lead Electrocardiogram Working Group. J Electrocardiol. 2009 Sep-Oct; 42(5):426-31. PMID: 19446840.
    Citations:    Fields:    Translation:Humans
  12. Frendl DM, Strauss DG, Underhill BK, Goldstein LB. Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. Stroke. 2009 Mar; 40(3):754-6. PMID: 19118240.
    Citations: 15     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Frendl's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (86)
Co-Authors (2)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.